Evolent Health, Inc Class A Common Stock (NY:EVH)

3.460 +0.070 (+2.06%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

April 15, 2025

Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts ↗

April 10, 2025

Via Benzinga

1 Growth Stock to Stash and 2 to Keep Off Your Radar

April 10, 2025

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care ↗

April 08, 2025

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

Via Benzinga

Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock ↗

March 10, 2025

Via Benzinga

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Evolent Health Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) ↗

February 12, 2025

Via Benzinga

What Analysts Are Saying About Evolent Health Stock ↗

January 14, 2025

Via Benzinga

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

March 20, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)

March 14, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers.

Via StockStory

3 Reasons to Sell EVH and 1 Stock to Buy Instead

March 07, 2025

Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have...

Via StockStory

Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect

February 23, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know.

Via StockStory

Cracking The Code: Understanding Analyst Reviews For Evolent Health ↗

November 08, 2024

Via Benzinga

Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts ↗

October 08, 2024

Via Benzinga

Evolent Health (EVH) Q4 2024 Earnings Call Transcript ↗

February 21, 2025

EVH earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Evolent Health (NYSE:EVH) Misses Q4 Sales Targets

February 20, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million. Next quarter’s revenue guidance...

Via StockStory

Topics Economy

Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For

February 19, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect.

Via StockStory

Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates

January 31, 2025

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was...

Via StockStory

Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining ↗

November 22, 2024

Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.

Via Benzinga

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul ↗

November 17, 2024

Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.

Via Benzinga

S&P 500 Tops 6,000; Sezzle Shares Spike Higher ↗

November 08, 2024

Via Benzinga

Topics Stocks

Dow Tops 44,000; US Consumer Sentiment Increases In November ↗

November 08, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 08, 2024

Via Benzinga

US Stocks Mixed; Fluor Earnings Miss Views ↗

November 08, 2024

Via Benzinga

Topics Earnings

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗

November 08, 2024

Via Benzinga

Evolent Health (EVH) Q3 2024 Earnings Call Transcript ↗

November 08, 2024

EVH earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Humana and Evolent Expand Partnership to Enhance Oncology Care

November 07, 2024

From Evolent Health, Inc.

Via Business Wire

Why Is Elevance Health Stock Trading Lower On Thursday? ↗

October 17, 2024

Evolent Health stock reacted negatively amid Elevance Health's mixed results and Medicaid utilization pressures.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.